Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pathology, Research and Practice

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.prp.2014.12.015PMID 25661069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of p-4ebp1 in Chinese gastric cancer patients and its correlation with prognosis.

  2013cited by this paper
• Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.

  2013cited by this paper
• Phosphorylated 4E‐binding protein 1 (p‐4E‐BP1): a novel prognostic marker in human astrocytomas

  2012cited by this paper
• Novel targeted agents for gastric cancer

  2012cited by this paper
• High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma

  2011cited by this paper
• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  2010cited by this paper
• New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress*

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• 7th Edition of the AJCC Cancer Staging Manual: Stomach

  2010cited by this paper
• Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

  2009cited by this paper
• Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity

  2009cited by this paper
• Novel targets in esophageal and gastric cancer: beyond antiangiogenesis

  2009cited by this paper
• Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.

  2009cited by this paper
• Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

  2009cited by this paper
• Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

  2008cited by this paper
• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  2008cited by this paper
• 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.

  2007cited by this paper
• Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer : A Report of the V 325 Study Group

  2006cited by this paper
• Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer

  2006cited by this paper
• Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

  2006cited by this paper
• When translation meets transformation: the mTOR story

  2006cited by this paper
• Novel targeted therapies in the treatment of gastric and esophageal cancer.

  2005cited by this paper
• Evolving chemotherapy for advanced gastric cancer.

  2005cited by this paper
• 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers.

  2000cited by this paper
• Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.

  1999cited by this paper
• Improving survival in gastric cancer: Review of 5‐year survival rates in English language publications from 1970

  1992cited by this paper
• The decline in gastric cancer: epidemiology of an unplanned triumph.

  1986cited by this paper

• High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis.

  2024cites this paper
• Mechanisms of traditional Chinese medicine in the treatment and prevention of gastric cancer.

  2024cites this paper
• A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration

  2022cites this paper
• Beyond molecular tumor heterogeneity: protein synthesis takes control

  2018cites this paper
• Meta-analysis of the prognostic value of p-4EBP1 in human malignancies

  2017cites this paper
• Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.

  2017cites this paper
• Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions

  2015cites this paper